The Food and Drug Administration says that a new analysis indicating genome editing in cattle can have unintended consequences underscores the importance of its regulatory approach to animal biotechnology.
To view this article, please
login. If you are not a current subscriber, you may sign up for a trial or view other subscription options
here.